Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for ELAN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 499.55M
March 31, 2026 499.38M
December 31, 2025 496.98M
September 30, 2025 496.83M
June 30, 2025 496.65M
March 31, 2025 496.46M
December 31, 2024 494.45M
September 30, 2024 494.33M
June 30, 2024 494.18M
March 31, 2024 494.05M
December 31, 2023 492.85M
September 30, 2023 492.68M
June 30, 2023 492.55M
March 31, 2023 492.42M
December 31, 2022 474.24M
September 30, 2022 474.12M
June 30, 2022 474.10M
Date Value
March 31, 2022 474.09M
December 31, 2021 473.12M
September 30, 2021 473.03M
June 30, 2021 473.00M
March 31, 2021 472.97M
December 31, 2020 471.92M
September 30, 2020 471.88M
June 30, 2020 398.90M
March 31, 2020 398.83M
December 31, 2019 373.01M
September 30, 2019 373.00M
June 30, 2019 365.71M
March 31, 2019 365.70M
December 31, 2018 365.64M
September 30, 2018 365.62M
June 30, 2018 365.62M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Zoetis, Inc. 414.15M
Eli Lilly & Co. 941.50M
ANI Pharmaceuticals, Inc. 22.97M
EyePoint, Inc. 84.98M
Amylyx Pharmaceuticals, Inc. 111.37M